TY - JOUR
T1 - Implementation of diabetes care and educational program via telemedicine in patients with COVID-19 in home isolation in Thailand
T2 - A real-worldexperience
AU - Harindhanavudhi, Tasma
AU - Areevut, Chatvara
AU - Sahakitrungruang, Taninee
AU - Tharavanij, Thipaporn
AU - Kietdumrongwong, Pongtorn
AU - Ngimruksa, Orasa
AU - Songsiri, Patitta
AU - Pitukweerakul, Siwadon
AU - Tanathornkirati, Nattamon
AU - Kaewprasert, Natthapon
AU - Thamcharoen, Ruchirek
AU - Karndumri, Krittadhee
AU - Saetung, Sunee
AU - Anthanont, Pimjai
AU - Kiattisakthavee, Pornpimol
AU - Putkong, Sarapee
AU - Chotwanvirat, Phawinpon
AU - Nartsupha Phattanasri, Chorthip
AU - Jinadit, Srikorn
AU - Korpaisarn, Sira
AU - Chusane, Manusvinee
AU - Samittarucksa, Rattanapan
AU - Lertrit, Amornpan
AU - Siangruangsang, Sanguansak
AU - Sanpawithayakul, Kanokporn
AU - Sathiravikarn, Waraporn
AU - Soisuwan, Sataporn
AU - Chevaisrakul, Parawee
AU - Imsakul, Kanokporn
AU - Thuptimtong, Pinradakarn
AU - Sakmanarit, Jandanee
AU - Somwang, Supaporn
AU - Prasartkaew, Hussamon
AU - Jerawatana, Ratanaporn
AU - Butadej, Siriwan
AU - Tachanivate, Porntip
AU - Jongjaroenprasert, Wallaya
AU - Sripatong, Jeeraphan
AU - Chobtangsilp, Sunanta
AU - Kamnirdsittiseree, Pattraphorn
AU - Savetkairop, Benjaporn
AU - Manosittisak, Warot
AU - Tantivatanasatien, Jitra
AU - Hathaidechadusadee, Amornrat
AU - Reutrakul, Sirimon
N1 - Funding Information:
Part of the supplies utilized in this study was funded by The Diabetes Association of Thailand.
Funding Information:
We would like to thank the following individuals and organizations, all in Bangkok, Thailand, for their donations of supplies, funds, and time in caring for the patients: Nittaya Phanuphak, MD, PhD, Pribta Clinic, Institute of HIV Research and Innovation, Ramathibodi Hospital Medical Supplies Room, Chulalongkorn Hospital's Pediatric Endocrinologist Group, Ramathibodi Type 1 Diabetes Club, Diabetes Association of Thailand, Paneeya Sutabutra, M.D., Srikorn Jinadit, M.D., Thitikan Wangapakul, M.D., Lertluk Weerasarn, M.D., Pakamon Dechsongjarus, M.D., Napassaree Clinic, Sangsom Reutrakul, Sakorn and Montira Thavisin, and Sangsom School.
Publisher Copyright:
© 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
PY - 2022/8
Y1 - 2022/8
N2 - Background: The coronavirus disease (COVID-19) outbreak in Bangkok led to a shortage of hospital capacity, and a home isolation system was set up. We described the process of diabetes self-management education and support (DSMES) and glycemic management via telemedicine, along with outcomes in home-isolated patients with COVID-19 infection. Methods: A retrospective chart review of glucose values, insulin and corticosteroids use, and outcomes was performed. Results: A volunteer group of 21 endocrinologists and 21 diabetes educators/nurses formed the consultation team. Patients with diabetes or at high-risk of diabetes and receiving corticosteroids were referred by primary volunteer physicians. Glucometers and related supplies, and insulin were donated, and delivered via same-day delivery services. A chat group of an individual patient/their caregiver, diabetes educator, endocrinologist, and primary physician was formed (majority via LINE® platform) to assess the patient's clinical status and need. Real-time virtual DSMES sessions were performed and treatments were adjusted via smartphone application or telephone. There were 119 patients (1,398 service days), mean (SD) age 62.0 (13.6) years, 85.7% had a history of type 2 diabetes, and 84.0% received corticosteroids. Insulin was used in 88 patients; 69 of whom were insulin-naïve. During the first 10 days, there were 2,454 glucose values. The mean glucose level on day 1 was 280.6 (122.3) mg/dL, and declined to 167.7 (43.4) mg/dL on day 10. Hypoglycemia occurred in 1.4% of the values. A majority of patients (79.5%) recovered at home. Conclusion: Diabetes care and DSMES delivered via telemedicine to patients on home isolation during COVID-19 pandemic was safe and effective.
AB - Background: The coronavirus disease (COVID-19) outbreak in Bangkok led to a shortage of hospital capacity, and a home isolation system was set up. We described the process of diabetes self-management education and support (DSMES) and glycemic management via telemedicine, along with outcomes in home-isolated patients with COVID-19 infection. Methods: A retrospective chart review of glucose values, insulin and corticosteroids use, and outcomes was performed. Results: A volunteer group of 21 endocrinologists and 21 diabetes educators/nurses formed the consultation team. Patients with diabetes or at high-risk of diabetes and receiving corticosteroids were referred by primary volunteer physicians. Glucometers and related supplies, and insulin were donated, and delivered via same-day delivery services. A chat group of an individual patient/their caregiver, diabetes educator, endocrinologist, and primary physician was formed (majority via LINE® platform) to assess the patient's clinical status and need. Real-time virtual DSMES sessions were performed and treatments were adjusted via smartphone application or telephone. There were 119 patients (1,398 service days), mean (SD) age 62.0 (13.6) years, 85.7% had a history of type 2 diabetes, and 84.0% received corticosteroids. Insulin was used in 88 patients; 69 of whom were insulin-naïve. During the first 10 days, there were 2,454 glucose values. The mean glucose level on day 1 was 280.6 (122.3) mg/dL, and declined to 167.7 (43.4) mg/dL on day 10. Hypoglycemia occurred in 1.4% of the values. A majority of patients (79.5%) recovered at home. Conclusion: Diabetes care and DSMES delivered via telemedicine to patients on home isolation during COVID-19 pandemic was safe and effective.
KW - COVID-19
KW - Diabetes
KW - Home isolation
UR - http://www.scopus.com/inward/record.url?scp=85128669252&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128669252&partnerID=8YFLogxK
U2 - 10.1111/jdi.13804
DO - 10.1111/jdi.13804
M3 - Article
C2 - 35394118
AN - SCOPUS:85128669252
SN - 2040-1116
VL - 13
SP - 1448
EP - 1457
JO - Journal of Diabetes Investigation
JF - Journal of Diabetes Investigation
IS - 8
ER -